Europe Structural Heart Devices Market Size & Outlook
Related Markets
Europe structural heart devices market highlights
- The Europe structural heart devices market generated a revenue of USD 3,467.6 million in 2023.
- The market is expected to grow at a CAGR of 16% from 2024 to 2030.
- In terms of segment, tavr (transcatheter aortic valve replacement) was the largest revenue generating type in 2023.
- LAAC (Left Atrial Appendage Closure) is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 3,467.6 million |
| Market revenue in 2030 | USD 9,814.9 million |
| Growth rate | 16% (CAGR from 2023 to 2030) |
| Largest segment | Tavr (transcatheter aortic valve replacement) |
| Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
| Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
Other key industry trends
- In terms of revenue, Europe region accounted for 24.7% of the global structural heart devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 8,094.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Structural Heart Devices Market Scope
Structural Heart Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| CardioKinetix | View profile | 11-50 | Menlo Park, California, United States, North America | http://www.cardiokinetix.com |
| Biomerics | View profile | 1001-5000 | Salt Lake City, Utah, United States, North America | http://biomerics.com |
| LivaNova PLC | View profile | 2900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | https://www.livanova.com |
| Lepu Medical | View profile | 10001+ | Changping, Beijing, China, Asia | http://en.lepumedical.com/ |
| St. Jude Medical | View profile | 10001+ | Saint Paul, Minnesota, United States, North America | http://www.sjm.com |
| Edwards Lifesciences Corp | View profile | 19800 | One Edwards Way, Irvine, CA, United States, 92614 | https://www.edwards.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Europe structural heart devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 54.31% in 2023. Horizon Databook has segmented the Europe structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The Europe structural heart devices market is experiencing a dynamic evolution, driven by a combination of factors such as the increasing incidence of Structural Heart Diseases (SHD), technological advancements in medical devices, and the robust healthcare infrastructure across the continent.
A study published in the European Heart Journal in 2018 highlighted that around 180,000 patients in the European Union and Northern America could be potential candidates for Transcatheter Aortic Valve Implantation (TAVI) annually. This number is projected to rise to 270,000 if the indications for TAVI are expanded to include low-risk patients.
This growing demand for structural heart devices is fueled by the need for more advanced treatment options, such as the development of innovative heart valves and annuloplasty rings, opening up new avenues for market expansion.
Reasons to subscribe to Europe structural heart devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe structural heart devices market databook
-
Our clientele includes a mix of structural heart devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe structural heart devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe structural heart devices market size, by country, 2018-2030 (US$M)
Europe Structural Heart Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
